Research
Sep 17, 2024
A Phase 2, open-label, multicenter, randomized study to evaluate the pharmacokinetics, safety, and acceptability of twice-yearly long-acting subcutaneous lenacapavir for pre-exposure prophylaxis in cisgender women in the United...
Mar 26, 2024
A multisite, open-label, randomized crossover study comparing adherence to a single daily dual prevention pill (DPP) versus FTC/TDF and Combined Oral Contraception separate pill dosing (2PR), given for pre-exposure prophylaxis and pregnancy prevention in people of...
Mar 26, 2024
The purpose of this study is to evaluate eligible participants who have completed DAIDS-sponsored pre-exposure prophylaxis (PrEP) studies HPTN 083 and HPTN 084 and associated sub-studies. Participants will continue receiving CAB LA and be followed for new HIV...
Feb 21, 2024
A Phase 2b, Double-Blind, Active Comparator-Controlled Study to Assess the Efficacy, Immunogenicity, and Safety of GRT R924 as a Next-Generation COVID-19 Booster Vaccine
Feb 20, 2024
This study will explore the use of community or home-based testing, including self-testing (HIVST) and preferences for linkage to confirmatory testing and treatment in cross-border migrants in Lesotho, a country with very high HIV prevalence as well as high rates of...
